Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease

Table 2 Characteristics of the distribution of serum bilirubin, albumin and INR levels in 10 patients with chronic liver failure at baseline, 1 and 4 mo after transplantation of autologous BMCs

Bilirubin(mg/dL)	Minimum	Maximum	Mean	Median	Standarddeviation	Relative meanchange frombaseline (%)
Baseline	1.2	4.83	2.78	2.45	1.16
1 mo	0.5	3.56	2.19	2.28	0.91	-21
4 mo	0.72	4.16	2.1	1.87	1.04	-24
Albumin (unit)
Baseline	2.5	4.4	3.47	3.5	0.51
1 mo	2.9	4.5	3.44	3.25	0.52	-1
4 mo	3.1	4.8	3.73	3.6	0.51	7
INR (unit)
Baseline	1.08	1.89	1.46	1.48	0.23
1 mo	1.1	1.94	1.44	1.43	0.23	-1
4 mo	1.16	1.75	1.42	1.43	0.18	-3